SLC22A5 gene encodes for the plasmalemmal carnitine transporter and the related disease encompasses a broad clinical spectrum including metabolic decompensation, cardiomyopathy, hypoglycemic hypoketotic encephalopathy or absence of symptoms [50, 51]. Here, SLC22A5 is linked to cardiomyopathy.